How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Clinical Trial Supply and Logistics for Pharmaceutical Market
- By Service Type: Packaging Services, Storage and Warehousing, Transportation and Distribution, Inventory Management, Temperature Monitoring and Control
- By Clinical Trial Phase: Phase I, Phase II, Phase III, Phase IV
- By Product Type: Biologics, Small Molecule Drugs, Biosimilars, Vaccines, Medical Devices
- By Temperature Requirement: Ambient, Refrigerated (2-8°C), Frozen (-20°C), Ultra-Low Temperature (-80°C and below)
- By End User: Pharmaceutical Companies, Biotechnology Firms, Contract Research Organizations (CROs), Academic and Research Institutions
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Packaging Services leads By Service Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 11 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 289 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.180 →
- 12 Company Profiles 11 players: SWOT & benchmarking p.188 →
Full report · locked preview
Everything inside the Clinical Trial Supply and Logistics for Pharmaceutical Market report
A complete, evidence-based study - 12 chapters and 121 sections covering market size, segmentation across 5 axes, regional analysis and 11 company profiles, forecast to 2033.
Segmentation covered
Service Type 5
Clinical Trial Phase 4
Product Type 5
Temperature Requirement 4
End User 4
Companies profiled
Catalent Inc.
PCI Pharma Services
Almac Group
Sharp Clinical Services
Kuehne + Nagel International AG
Baxter BioPharma Solutions (a division of Baxter International)
Fisher Clinical Services (Thermo Fisher Scientific)
Marken (a UPS company)
World Courier (a part of AmerisourceBergen)
DPx Holdings
Inc.
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
11 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Catalent Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →PCI Pharma Services
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Almac Group
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Sharp Clinical Services
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Kuehne + Nagel International AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Baxter BioPharma Solutions (a division of Baxter International)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Fisher Clinical Services (Thermo Fisher Scientific)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Marken (a UPS company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →World Courier (a part of AmerisourceBergen)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →DPx Holdings
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,023M by 2033 · 8.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Packaging Services52.9
- Storage and Warehousing9.1
- Transportation and Distribution11.6
- Inventory Management12.5
- Temperature Monitoring and Control13.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$895.5M → $1,709M · 8.4%
Europe$624.2M → $1,054M · 6.8%
Asia Pacific$569.9M → $985.5M · 7.1%
Latin America$352.8M → $582.1M · 6.5%
Middle East and Africa$271.4M → $508.5M · 8.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.962026
7.972027
7.972028
8.002029
8.002030
8.012031
8.032032
8.042033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Catalent Inc.26.1
- PCI Pharma Services11.0
- Almac Group8.3
- Sharp Clinical Services9.6
- Kuehne + Nagel International AG6.2
- Baxter BioPharma Solutions (a division of Baxter International)10.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Service Type17.0%
Clinical Trial Phase14.5%
Product Type21.5%
Temperature Requirement19.6%
End User27.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.3
- Europe21.8
- Asia Pacific20.4
- Latin America12.0
- Middle East and Africa10.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Catalent Inc. | 98 | 85 | 89 | 75 | 91 | 80 | 86 |
| PCI Pharma Services | 89 | 91 | 93 | 72 | 71 | 79 | 83 |
| Almac Group | 76 | 82 | 70 | 75 | 77 | 87 | 78 |
| Sharp Clinical Services | 66 | 70 | 82 | 63 | 78 | 62 | 70 |
| Kuehne + Nagel International AG | 75 | 74 | 53 | 71 | 76 | 60 | 68 |
| Baxter BioPharma Solutions (a division of Baxter International) | 66 | 55 | 69 | 58 | 59 | 47 | 59 |
| Fisher Clinical Services (Thermo Fisher Scientific) | 45 | 50 | 47 | 46 | 46 | 64 | 50 |
| Marken (a UPS company) | 58 | 40 | 55 | 45 | 53 | 35 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Catalent Inc.
- PCI Pharma Services
- Almac Group
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Catalent Inc. | ✓ | ✓ | ✓ | ◐ | ◐ | ✓ |
| PCI Pharma Services | ◐ | ◐ | ✓ | ✓ | ◐ | ✓ |
| Almac Group | ✓ | ◐ | ✓ | ◐ | ✓ | ◐ |
| Sharp Clinical Services | ◐ | ✓ | ✓ | ◐ | ◐ | ◐ |
| Kuehne + Nagel International AG | ✓ | ◐ | − | − | ✓ | − |
| Baxter BioPharma Solutions (a division of Baxter International) | − | − | − | ◐ | ◐ | ◐ |
| Fisher Clinical Services (Thermo Fisher Scientific) | − | − | − | − | − | ◐ |
| Marken (a UPS company) | ◐ | − | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Catalent Inc.86
2PCI Pharma Services83
3Almac Group78
4Sharp Clinical Services70
5Kuehne + Nagel International AG68
6Baxter BioPharma Solutions (a division of Baxter International)59
7Fisher Clinical Services (Thermo Fisher Scientific)50
8Marken (a UPS company)48
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Catalent Inc.PCI Pharma ServicesAlmac Group
Challenger2
Strong scale, closing on the leaders.
Sharp Clinical ServicesKuehne + Nagel International AG
Contender1
Focused players with pockets of strength.
Baxter BioPharma Solutions (a division of Baxter International)
Niche2
Specialists in a single segment or region.
Fisher Clinical Services (Thermo Fisher Scientific)Marken (a UPS company)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Service Type in North America, then scale across Clinical Trial Supply and Logistics for Pharmaceutical Market — a $569M beachhead inside a $8.32B market.
Beachhead (SOM)$569Mobtainable near-term
Serviceable (SAM)$3.09Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Packaging Services
Best fit — highest urgency & budget in Service Type.
Economic buyer78 fit
Storage and Warehousing
Strong fit — clear ROI and a fast path to value.
End user64 fit
Transportation and Distribution
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Service Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Clinical Trial Phase & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Product Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel25%
Digital / self-serve23%
Marketplaces10%
Positioning & messaging
§GTM 2 · p.194 →For Service Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Clinical Trial Supply and Logistics for Pharmaceutical Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified24%
Evaluation15%
Closed-won6%
$9.4KCAC
$38KLTV
4.0:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Clinical Trial Supply and Logistics for Pharmaceutical Market is a durable-growth opportunity — $5.03B by 2033, compounding at 8.9%.
TAM · 2025$2.55Btoday
TAM · 2033$5.03Bforecast
CAGR8.9%2027–2033
Cumulative$33.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.03BTotal addressable market
SAM$2.06BServiceable available market
SOM$340MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.9% CAGR
Demand compounds through 2033, outpacing GDP across Service Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Service Type moving from early to mainstream — durable secular demand.
Consolidation upside
11+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.03BLarge & growingTAM by 2033 at 8.9% CAGR
$2.06BServiceable nowreachable with today’s model
$340MBeachhead winobtainable near-term share
11+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.92BBear5.8% CAGR
$5.03BBase8.9% CAGR
$6.44BBull11.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Clinical Trial Phase optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Clinical Trial Supply and Logistics for Pharmaceutical Market — a $3.23B market by 2033. Plan: grow share from 5.1% to 11.1%.
Market size · 2033$3.23Btotal addressable
Market CAGR5.5%2027–2033
Target share11.1%from 5.1% today
Revenue ambition$358Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 5.1% | 11.1% | Ahead |
| Revenue | $176M | $358M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 31.9% | 40.9% | On track |
| Customer retention | 90.9% | 93.2% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Service Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Clinical Trial Phase capability
A defensible second engine — invest in Clinical Trial Phase to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Service Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Clinical Trial Phase
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $49M capacity & capability investment
- Greenlight bolt-on M&A in Clinical Trial Phase
- Authorise North America expansion plan
- Fund R&D program for Service Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossBehind
- Input-cost & supply riskBehind
- Regulatory / policy changeAhead
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Clinical Trial Supply and Logistics for Pharmaceutical Market conversation — a $10.1B market you can size, segment and defend in minutes.
Market size · 2033$10.1Btotal opportunity
Growth10.7%CAGR to 2033
Addressable buyers1,432+accounts in scope
Typical ROI6.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Service Type
Goal Grow share in Service Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.5×return on cost, year one
< 4 mopayback period
$56K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
11+players profiled in this market
Coverage includes
Catalent Inc.PCI Pharma ServicesAlmac GroupSharp Clinical ServicesKuehne + Nagel International AGBaxter BioPharma Solutions (a division of Baxter International)Fisher Clinical Services (Thermo Fisher Scientific)Marken (a UPS company)+3 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Clinical Trial Supply and Logistics for Pharmaceutical Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Clinical Trial Supply and Logistics for Pharmaceutical Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Clinitek Advantus Analyzer Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportClinker Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportClinkerr Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportClip Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportClip On Wheel Balance Weight Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportClip-On Ammeter Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportClip-on Wireless Microphone Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportClivia Miniata Market
Market size, share, segmentation and regional forecast.
$523M market · 2025 base year
View reportCLMV Specialised Container Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportClobetasone butyrate CAS 25122-57-0 Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportClock & Timer Development Kits Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportClock Buffer IC Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.